Tevogen Inc. SEC filings TVGN

Tevogen Inc. has 309 filings in SEC EDGAR's recent list, going back to Jun 10, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Aug 3, 2026 Aug 3, 2026
PRE 14A Preliminary proxy statement Jul 23, 2026 Jul 23, 2026
DEF 14A Proxy statement Jan 26, 2026 Jan 26, 2026
PRE 14A Preliminary proxy statement Jan 16, 2026 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Dec 4, 2023 Dec 4, 2023
PRE 14A Preliminary proxy statement Nov 13, 2023 Nov 13, 2023
DEFA14A Additional proxy material Jan 26, 2023 —
DEF 14A Proxy statement Jan 20, 2023 Feb 3, 2023
PRE 14A Preliminary proxy statement Jan 10, 2023 Jan 10, 2023

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TVGN (Nasdaq), TVGNW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
, Emerging growth company
SEC CIK
1860871
Former names
Tevogen Bio Holdings Inc. (until Jul 30, 2026); Semper Paratus Acquisition Corp (until Feb 15, 2024)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.